| Jyotsna Adma, MD | |
|
4300 Brenner Dr, Kansas City, KS 66104-1163 | |
| (913) 890-7400 | |
| (913) 334-0284 |
| Full Name | Jyotsna Adma |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 4300 Brenner Dr, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245457217 | NPI | - | NPPES |
| 036.153640 | Other | IL | ILLINOIS LICENSE |
| Entity Name | Olathe Health Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784639 PECOS PAC ID: 7618881905 Enrollment ID: O20031119000719 |
News Archive
Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
Most animals appear symmetrical at first glance, but we're full of internal lop-sidedness.
› Verified 8 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
Most animals appear symmetrical at first glance, but we're full of internal lop-sidedness.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jyotsna Adma, MD 15316 Perry St, Overland Park, KS 66221-7504 Ph: (913) 962-1398 | Jyotsna Adma, MD 4300 Brenner Dr, Kansas City, KS 66104-1163 Ph: (913) 890-7400 |
News Archive
Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
Most animals appear symmetrical at first glance, but we're full of internal lop-sidedness.
› Verified 8 days ago
Joan M. T. Collison, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 4015, Kansas City, KS 66160 Phone: 913-588-1300 Fax: 913-588-1310 | |
Dr. Andrea Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3599 Rainbow Blvd, Kansas City, KS 66103 Phone: 913-588-6970 | |
James S Appelbaum, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 440, Kansas City, KS 66112 Phone: 913-596-7286 Fax: 913-596-7248 | |
Dr. Robert T. Reynders, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160 Phone: 913-588-3807 | |
Ahmad Abuzinadah, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Ms 2012, Kansas City, KS 66160 Phone: 913-588-6970 Fax: 913-588-6965 | |
Dr. Thomas Bryan Hall, Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Department Of Psychiatry, Kansas City, KS 66160 Phone: 913-588-6400 | |
Debra Jean Kelsh, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-1304 Fax: 913-588-1310 |